[Economic feasibility study and reimbursement rules--illustrated by a concrete example].
Kolenda
Karen
K
Friis
Mogens Laue
ML
D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000191:economics; D002318:Cardiovascular Diseases / Q000517:prevention & control; D016527:Drug Costs; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000191:economics; D004364:Pharmaceutical Preparations / Q000191:economics*; D012051:Reimbursement Mechanisms
D000924:Anticholesteremic Agents; D000960:Hypolipidemic Agents; D004364:Pharmaceutical Preparations